GC30875
CCG 203769
Also known as 4-butyl-2-ethyl-1,2,4-thiadiazolidine-3,5-dione
CCG 203769 is a selective G protein signaling (RGS4) inhibitor, which blocks the RGS4-Gαo protein-protein interaction in vitro with an IC50 of 17 nM
ChemicalCAS410074-60-1MW202.27FormulaC8H14N2O2S
- CAS number
- 410074-60-1
- Molecular weight
- 202.27
- Formula
- C8H14N2O2S
- Solubility
- DMSO ： 62·5 mg/mL (308·99 mM)
- InChIKey
- WTFFYZGCISALRI-UHFFFAOYSA-N
- Catalogue number
- GC30875
- Brand
- GLPBIO
Computed properties PubChem CID 6539137 · XLogP 1.6 · TPSA 65.9 Ų · H-bond donors 0
- XLogP
- 1.6
- TPSA
- 65.9 Ų
- H-bond donors
- 0
- H-bond acceptors
- 3
- Rotatable bonds
- 4
- Heavy atoms
- 13
SMILES CCCCN1C(=O)N(SC1=O)CC
Computed descriptors from PubChem (CID 6539137), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il